Seelos Announces Second Postponement of its Annual Meeting of Stockholders
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 24 2024
0mins
Source: PRnewswire
Annual Meeting Postponement: Seelos Therapeutics has postponed its 2024 Annual Meeting of Stockholders to November 25, 2024, due to anticipated lack of quorum and to allow more time for proxy solicitation. The meeting will be held virtually.
Voting Recommendations: The Board of Directors recommends stockholders vote in favor of the nominees and proposals outlined in the proxy statement, urging those who haven't voted to do so before the new meeting date.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
